MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Atorvastatin 80mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Atorvastatin formulations Explore other Atorvastatin 80mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Atorvastatin 80mg tablets (Rudipharm Ltd)

Explore other Atorvastatin formulations Explore other Atorvastatin 80mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Atorvastatin 80mg tablets (Sandoz Ltd)

Explore other Atorvastatin formulations Explore other Atorvastatin 80mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Atorvastatin 80mg tablets (Sigma Pharmaceuticals Plc)

Explore other Atorvastatin formulations Explore other Atorvastatin 80mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Atorvastatin 80mg tablets (Sun Pharma UK Ltd)

Explore other Atorvastatin formulations Explore other Atorvastatin 80mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Atorvastatin 80mg tablets (Teva UK Ltd)

Explore other Atorvastatin formulations Explore other Atorvastatin 80mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

Atrolak XL 150mg tablets (Accord-UK Ltd)

Explore other Quetiapine formulations Explore other Quetiapine 150mg modified-release tablets suppliers

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Seroquel XL 50mg tablets (Luye Pharma Ltd).

Use with caution

Atrolak XL 200mg tablets (Accord-UK Ltd)

Explore other Quetiapine formulations Explore other Quetiapine 200mg modified-release tablets suppliers

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Seroquel 200mg tablets (Luye Pharma Ltd) and Quetiapine 200mg tablets (Accord Healthcare Ltd).

Use with caution

Atrolak XL 300mg tablets (Accord-UK Ltd)

Explore other Quetiapine formulations Explore other Quetiapine 300mg modified-release tablets suppliers

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Seroquel XL 300mg tablets (Luye Pharma Ltd).

Use with caution

Atrolak XL 400mg tablets (Accord-UK Ltd)

Explore other Quetiapine formulations Explore other Quetiapine 400mg modified-release tablets suppliers

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Seroquel XL 400mg tablets (Luye Pharma Ltd).

Use with caution

Atrolak XL 50mg tablets (Accord-UK Ltd)

Explore other Quetiapine formulations Explore other Quetiapine 50mg modified-release tablets suppliers

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Seroquel XL 50mg tablets (Luye Pharma Ltd).

Use with caution

Augmentin 375mg tablets (GlaxoSmithKline UK Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 250mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 375mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd).

Use with caution

Augmentin 625mg tablets (GlaxoSmithKline UK Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Augmentin 625mg tablets (Sigma Pharmaceuticals Plc)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

No Stability Information

Auranofin 3mg tablets (Special Order)

Explore other Auranofin formulations Explore other Auranofin 3mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.
Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.